loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Rifampin

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Rifampin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 182Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    J&J's tuberculosis Sirturo lands full US, EU approvals
    J&J's tuberculosis Sirturo lands full US, EU approvals

    08 Jul 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/jjs-tuberculosis-med-sirturo-lands-full-us-european-approvals-after-more-decade

    FIERCE PHARMA
    08 Jul 2024
    Share Share
    NPPA invokes Para 3 of DPCO to direct Macleods to supply anti-TB drug to CMSS
    NPPA invokes Para 3 of DPCO to direct Macleods to supply anti-TB drug to CMSS

    15 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169748&sid=1

    PHARMABIZ
    15 Jun 2024
    Share Share
    Enforcement Report - Week of April 17, 2024
    Enforcement Report - Week of April 17, 2024

    17 Apr 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-17-2024-82633.pdf

    FDA
    17 Apr 2024
    Share Share
    Lupin, Glenmark recall drugs in US market: USFDA
    Lupin, Glenmark recall drugs in US market: USFDA

    10 Apr 2024

    // MONEYCONTROL

    https://www.moneycontrol.com/news/business/lupin-glenmark-recall-drugs-in-us-market-usfda-12613191.html

    MONEYCONTROL
    10 Apr 2024
    Share Share
    Enforcement Report - Week of February 7, 2024
    Enforcement Report - Week of February 7, 2024

    07 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-7-2024-67267.pdf

    FDA
    07 Feb 2024
    Share Share
    Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards
    Fighting tuberculosis: EUROAPI’s rifampicin API meets new requirements for nitrosamine impurity standards

    24 Oct 2023

    // PRESS RELEASE

    https://www.euroapi.com/en/fighting-tuberculosis-EUROAPI-rifampicin-meets-new-requirements-for-nitrosamine-impurity-standards

    PRESS RELEASE
    24 Oct 2023
    Share Share